CompletedNot Applicable

Ultrasonographic Response to Cervical and Upper Thoracic SNAG in Medial Epicondylitis

Egypt60 participantsStarted 2025-09-08

Plain-language summary

Aim of the work : 1. To detect if there is any change would occur in the neovascularity and echogenicity after using cervical and upper thoracic SNAG or not in ME patients. 2. To find the effect of cervical and upper thoracic SNAG on pain, function of upper extremities, grip strength in ME comparing with traditional treatment alone

Who can participate

Age range35 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ranges from 35 to 50 years old in both sexes. * Patients with LE that diagnosed by orthopedist. * Pain onset is more than 3 months appear primarily with use or rest or in both, also , it appear with deep palpation of the medial epicondyle . Exclusion Criteria: * • Rheumatoid Arthritis . * Skin infection. * History of previous elbow surgery. * Any pathology in the shoulder joint. * Neurologic deficit in upper extremity. * Cervical disc prolapse and radiculopathy C5,6. * Dislocation of elbow joint. * Recent fractures of upper extremity. * Arthrosis of the radiohumeral joint. * Osteochondritis dissecans. * Osteonecrosis. * Plica synovialis. * Participants receiving other treatment, in the form of physical therapy or medication, for the duration of the study that may interfere with the results of this study.

What they're measuring

Colour Ultrasonography

Timeframe: Baseline and after one month

Trial details

NCT IDNCT07187102

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-25

View on ClinicalTrials.gov More Medial Epicondylitis trials